Wearable technologies are starting to reshape how people manage health. Continuous glucose monitors that measure blood sugar ...
Senseonics VP of Product Development Hari Sree explains the tech behind the Eversense 365-day CGM and what’s next in the ...
Samsung announced a spate of new Mini LED TVs – TVs that use LED backlights behind the display to selectively light areas of color and leave darker areas dim or unlit, creating better contrast than ...
Microsoft revealed that it is developing a data center networking technology using micro LED technology with the potential to reduce energy consumption and improve performance as demand for AI and ...
Add Yahoo as a preferred source to see more of our stories on Google. Michael Ford was not in good health, but his Type 2 diabetes was manageable. His son, Davonte Ford, was his full-time caregiver — ...
Michael Ford was not in good health, but his Type 2 diabetes was manageable. His son, Davonte Ford, was his full-time caregiver — bathing Michael, administering his medications and dutifully ...
Jessie Inchauspé, aka the "Glucose Goddess," built a brand on sharing her tips for balancing blood sugar. She said wearing a CGM helped her understand blood sugar in real time for better energy and ...
DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom ...
When automating your smart home, much of the attention centers on cameras and lights, but I believe HomeKit door sensors are arguably among the most critical devices to add to your setup. I’ve written ...
Feb. 4 (UPI) --Officials for Abbott Diabetes Care have recalled some of the company's FreeStyle Libre 3 and FreeStyle Libre 3 Plus continuous glucose monitor sensors for people with diabetes. The Food ...
Diabetes is incredibly common. According to the American Diabetes Association, around 7 million people in the United States are undiagnosed, with 1 in 3 Americans at risk for developing type 2 ...